Reviva Pharmaceuticals Changes Auditors to EisnerAmper LLP

Ticker: RVPH · Form: 8-K · Filed: Jun 6, 2025

Sentiment: neutral

Topics: auditor-change, accounting

TL;DR

Reviva Pharmaceuticals swapped auditors from WithumSmith+Brown to EisnerAmper LLP, effective June 3, 2025.

AI Summary

Reviva Pharmaceuticals Holdings, Inc. announced on June 3, 2025, a change in its certifying accountant. The company has dismissed its previous independent registered public accounting firm, WithumSmith+Brown, PC, and has appointed EisnerAmper LLP as its new principal accountant. This change is effective immediately.

Why It Matters

A change in auditors can sometimes signal underlying issues or a strategic shift within a company, potentially impacting investor confidence.

Risk Assessment

Risk Level: medium — Changes in auditors, especially without detailed explanation, can sometimes precede or coincide with other significant corporate events or financial scrutiny.

Key Players & Entities

FAQ

When was the change in certifying accountant effective?

The change in certifying accountant was effective as of June 3, 2025.

Who was Reviva Pharmaceuticals' former certifying accountant?

Reviva Pharmaceuticals' former certifying accountant was WithumSmith+Brown, PC.

Who is Reviva Pharmaceuticals' new principal accountant?

Reviva Pharmaceuticals' new principal accountant is EisnerAmper LLP.

Did the company have any disagreements with its former accountant?

The filing does not explicitly state any disagreements with WithumSmith+Brown, PC.

What is the company's principal executive office address?

The company's principal executive office is located at 10080 N. Wolfe Rd., Suite SW3-200, Cupertino, CA 95014.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 6, 2025 regarding REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH).

View full filing on EDGAR

View on Read The Filing